APH

ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) ("ALDA" or "the
Company") is monitoring reports of new "Superbugs" that are highly resistant to
nearly all antibiotics, including penicillin-like antibiotics that possess broad
spectrum antibacterial properties and are typically used as a last resort. The
new strains of antibiotic-resistant E. coli and Klebsiella were created when
genetic material that codes for an antibiotic-digesting enzyme was incorporated
from other species. Such genetic "swapping" is common among bacteria and is a
major cause of antibiotic resistance. Although primarily observed in Pakistan,
India and the UK, similar infections have been reported in US, Canada, Australia
and the Netherlands and international researchers are concerned that these new
strains could become a major global health problem.


To reduce the spread of these bacteria, health authorities are recommending
proper hand hygiene and disinfection procedures. Dr. Terrance Owen, President &
CEO comments, "Using effective hand sanitizers and disinfectant products is an
important step in keeping one's environment safe. ALDA's products contain 70%
ethanol and benzalkonium chloride which have both proven to be very effective
against E. coli and other resistant bacteria, such as MRSA. Although the
threatened H1N1 pandemic did not materialize, it certainly made people aware of
the need for products that can reduce the transmission of infectious diseases.
The lessons learned may prove to be very useful as we face ever-increasing
numbers of Superbugs."


About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived
from its patented T36(R) technology. The company trades on the TSX Venture
Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The
Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and
the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the
Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian
Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant
cleaning products. The Company was also selected as one of the TSX Venture 50
companies in the Technology and Life Sciences sector for 2010.


Terrance G. Owen, Ph.D., MBA, President & CEO 

ALDA Pharmaceuticals Corp.

The Units, common shares, warrants and the common shares issuable upon exercise
of the warrants have not been registered under the United States Securities Act
of 1933 (the "Act") and may not be offered or sold absent registration under the
Act or an applicable exemption from the registration requirements thereof. This
news release does not constitute an offer to sell or a solicitation of an offer
to buy, nor shall there be any sale of these securities in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such jurisdiction or an
exemption therefrom.


Cautionary Note Regarding Forward-looking Statements: Information in this press
release that involves ALDA's expectations, plans, intentions or strategies
regarding the future are forward-looking statements that are not facts and
involve a number of risks and uncertainties. ALDA generally uses words such as
"outlook", "will", "could", "would", "might", "remains", "to be", "plans",
"believes", "may", "expects", "intends", "anticipates", "estimate", "future",
"plan", "positioned", "potential", "project", "remain", "scheduled", "set to",
"subject to", "upcoming", and similar expressions to help identify
forward-looking statements. The forward-looking statements in this release are
based upon information available to ALDA as of the date of this release, and
ALDA assumes no obligation to update any such forward-looking statements.
Forward-looking statements believed to be true when made may ultimately prove to
be incorrect. These statements are not guarantees of the future performance of
ALDA and are subject to risks, uncertainties and other factors, some of which
are beyond its control and may cause actual results to differ materially from
current expectations.

Grafico Azioni Aphria Inc. (TSXV:APH)
Storico
Da Apr 2024 a Mag 2024

Grafico Azioni Aphria Inc. (TSXV:APH)
Storico
Da Mag 2023 a Mag 2024